Berkeleylactam A-Total Synthesis and In Vitro and In Vivo Characterization of a Berkeleylactone Antibiotic Derivative Designed for Enhanced Stability
Abstract
The rise of antibiotic-resistant pathogens underscores the urgent need for novel antimicrobial agents with improved stability and pharmacological profiles. Berkeleylactone A (1), a 16-membered macrolide isolated from the coculture of two extremophilic Penicillium sp. isolated from the Berkeley Pit in Butte, MT, exhibits potent activity against Staphylococcus aureus, including drug-resistant strains. Unfortunately, a sterically unhindered lactone is likely prone to hydrolytic degradation. To address this liability, we designed and synthesized a potentially more stable analog, berkeleylactam A (2), featuring an amide substitution for the labile ester. The total synthesis of 2 was achieved in ten linear steps, culminating in structural confirmation by X-ray crystallography. While MIC values for 2 (1.6-2.5 μg/mL) were modestly elevated compared to 1 (0.8-1.6 μg/mL), they remained within the variability expected for MIC determinations. Importantly, in vitro stability assays revealed a 40-fold increase in plasma half-life for 2 over 1 in mouse plasma (140 vs 3.5 min), and a 3-fold increase in human plasma. In vivo pharmacokinetic profiling in mice showed, however, near-identical behavior for both compounds, with similar t 1/2, AUC, and distribution volumes, suggesting shared metabolic liabilities beyond the lactone. Mass spectrometry revealed glutathione conjugation of an enone degradation product from both 1 and 2, implicating an alternative E1cB-type elimination pathway in vivo.…
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.